healthTECH JAPAN 2026

AI for drug discovery, Deep learning, In silico discovery, Drug discovery platforms, AI image analysis, Personalized medicine, Real world data, Genomics data, Genome analysis, Genome editing, Next generation sequencer genetic testing, Non-pharmacotherapy systems (disease treatment apps), Adherence products (disease management apps), Health function improvement and prevention apps, Security software, Cloud, Digital biomarkers, Digital diagnostics, Remote diagnostics, Remote patient monitoring, Medication adherence tools, Drug device combinations, Drug delivery systems, Presymptomatic diseases, Epidemic disease prediction and measurement, Wearable devices, Lifestyle apps, Vital information monitoring and sensing, Electronic medical records systems, Patient portals, Diagnostic management tools, Functional foods, Digital insurance, Health support services, Personal health records
healthTECH JAPAN was held for the first time in 2020, based on the concept of the fusion of healthcare and digital technology data. The exhibition will be held by developing the Healthcare Zone" and "Digital Zone," which have been the focus of BioJapan, one of Asia's largest events in the life science industry since 1986. This exhibition will bring together digital solutions for treatment and health, and promote the creation of a new healthcare market and business. In addition, the healthcare industry is expected to utilize digital medicine and digital therapeutics (DTx) in particular. As a business matching event, this exhibition will be held in conjunction with BioJapan and Regenerative Medicine JAPAN, which have been highly acclaimed in the U.S. and Europe, and it aims to be a matching platform for all aspects of healthcare, covering not only drug discovery and cell therapy, but also prevention, diagnosis, management, and treatment.
Held with concurrent exhibitions.